216 related articles for article (PubMed ID: 6150278)
1. Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination.
Simonsen O; Kjeldsen K; Heron I
Lancet; 1984 Dec; 2(8414):1240-2. PubMed ID: 6150278
[TBL] [Abstract][Full Text] [Related]
2. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination.
Simonsen O; Badsberg JH; Kjeldsen K; Møller-Madsen B; Heron I
Acta Pathol Microbiol Immunol Scand C; 1986 Apr; 94(2):77-82. PubMed ID: 3739720
[TBL] [Abstract][Full Text] [Related]
3. Immunity against diphtheria 25-30 years after primary vaccination in childhood.
Kjeldsen K; Simonsen O; Heron I
Lancet; 1985 Apr; 1(8434):900-2. PubMed ID: 2858748
[TBL] [Abstract][Full Text] [Related]
4. Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination.
Simonsen O; Klaerke M; Klaerke A; Bloch AV; Hansen BR; Hald N; Hau C; Heron I
Acta Pathol Microbiol Immunol Scand C; 1986 Oct; 94(5):219-25. PubMed ID: 3565028
[TBL] [Abstract][Full Text] [Related]
5. Immunity against diphtheria and tetanus in the age group 30-70 years.
Kjeldsen K; Simonsen O; Heron I
Scand J Infect Dis; 1988; 20(2):177-85. PubMed ID: 3399837
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus.
Simonsen O; Bentzon MW; Kjeldsen K; Venborg HA; Heron I
Vaccine; 1987 Jun; 5(2):115-22. PubMed ID: 3604393
[TBL] [Abstract][Full Text] [Related]
7. Immunity against tetanus and response to revaccination in surgical patients more than 50 years of age.
Simonsen O; Block AV; Klaerke A; Klaerke M; Kjeldsen K; Heron I
Surg Gynecol Obstet; 1987 Apr; 164(4):329-34. PubMed ID: 3563844
[TBL] [Abstract][Full Text] [Related]
8. Immunity and immunization of children against tetanus in sweden.
Christenson B; Böttiger M
Scand J Infect Dis; 1991; 23(5):643-7. PubMed ID: 1767261
[TBL] [Abstract][Full Text] [Related]
9. [Preventive tetanus immunization and avoidance of side effects of booster immunization].
Schröder JP; Kuhlmann WD
Dtsch Med Wochenschr; 1992 Dec; 117(50):1903-6. PubMed ID: 1459020
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
[TBL] [Abstract][Full Text] [Related]
11. Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers.
Sangpetchsong V; Vichaikummart S; Vichitnant A; Podhipak A
Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):275-80. PubMed ID: 6523168
[TBL] [Abstract][Full Text] [Related]
12. Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response.
Simonsen O; Klaerke M; Jensen JE; Kjeldsen K; Hau C; Heron I
J Trauma; 1987 Dec; 27(12):1358-61. PubMed ID: 3694727
[TBL] [Abstract][Full Text] [Related]
13. Tetanus immunity in individuals aged 50 years or older in Kashan, Iran.
Razzaghi R; Khalifesoltani A; Heravi MM; Akbari H
Acta Med Iran; 2011; 49(6):379-82. PubMed ID: 21874642
[TBL] [Abstract][Full Text] [Related]
14. Active immunization against tetanus in man. II. Combined active and passive prophylaxis with human tetanus immune globulin.
Ullberg Olsson K; Eriksson E; Lundström R; Wiholm S
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):191-201. PubMed ID: 134538
[TBL] [Abstract][Full Text] [Related]
15. Immunization against neonatal tetanus in New Guinea.
Hardegree MC; Barile MF; Pittman M; Schofield FD; Maclennan R; Kelly A
Bull World Health Organ; 1970; 43(3):439-51. PubMed ID: 5312998
[TBL] [Abstract][Full Text] [Related]
16. The primary serological response to a single dose of adsorbed tetanus toxoid, high concentration type.
Breman JG; Wright GG; Levine L; Latham WC; Compaoré KP
Bull World Health Organ; 1981; 59(5):745-52. PubMed ID: 6976235
[TBL] [Abstract][Full Text] [Related]
17. Single - dose immunization of human subjects against tetanus.
Matveev KI; Sergeeva TI; Zarubina EK; Minaeva ZL
J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):112-20. PubMed ID: 944211
[TBL] [Abstract][Full Text] [Related]
18. Immunity to tetanus: tetanus antitoxin and anti-BIIb in human sera.
German-Fattal M; Bizzini B; German A
J Biol Stand; 1987 Jul; 15(3):223-30. PubMed ID: 3611114
[TBL] [Abstract][Full Text] [Related]
19. Active immunization against tetanus in guinea-pigs. An attempt to evaluate "rapid immunization" with tetanus vaccine.
Ullberg-Olsson K
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):166-72. PubMed ID: 134536
[TBL] [Abstract][Full Text] [Related]
20. [Formation of tetanus antitoxin in man as related to the immunizing dose of antigen and the number of inoculations. 3. Duration of retention of tetanus antitoxin in the vaccinated and the effectiveness of repeated revaccination].
Dzhavrova IK; Kashintseva NS; Matveev KI; Khramova SA
Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):22-5. PubMed ID: 5735228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
